OneMedNet (NASDAQ:ONMD) CEO Sells $10,802.16 in Stock

OneMedNet Corporation (NASDAQ:ONMD) CEO Aaron Green sold 1,667 shares of the firm’s stock in a transaction dated Thursday, September 24th. The stock was sold at an average price of $6.48, for a total value of $10,802.16. Following the sale, the chief executive officer directly owned 247,971 shares in the company, valued at approximately $1,606,852.08. This represents a 0.67% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Aaron Green also recently made the following trade(s):

• On Tuesday, September 22nd, Aaron Green sold 5,000 shares of OneMedNet stock. The shares were sold at an average price of $7.39, for a total value of $36,950.00.

OneMedNet Stock Performance

NASDAQ ONMD traded down $0.52 during trading hours on Friday, hitting $4.30. 24,653 shares of the company traded hands, compared to its average volume of 69,105. The business’s 50-day moving average is $6.24 and its 200-day moving average is $7.32. OneMedNet Corporation has a twelve month low of $4.30 and a twelve month high of $42.20. The stock has a market capitalization of $25.50 million, a price-to-earnings ratio of -2.69 and a beta of 1.14.

Analyst Ratings Changes

Separately, Weiss Ratings raised shares of OneMedNet from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday, August 24th. One equities research analyst has rated the stock with a Sell rating. According to data from MarketBeat, the stock currently has an average rating of “Sell”.

OneMedNet Company Profile

OneMedNet Corporation is a healthcare technology company that develops infrastructure for accessing, managing and analyzing medical data. Its platform is designed to help healthcare providers, researchers, life sciences companies and other authorized users work with clinical and medical-imaging information while keeping the underlying data within the organization that controls it.

The company’s technology uses a federated data model, allowing participating institutions to collaborate on data analysis without routinely transferring sensitive patient information to a centralized repository.